Krista Maye Crow

Dr. Krista Maye Crow

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2023 in Nature Reviews Urology
Verified
Journal Article
Closed access
PDF file
KGKatherine W. Greeson
Katherine W. Greeson
KCKrista Maye Crow
Krista Maye Crow
RER. Clayton Edenfield
R. Clayton Edenfield
Charles EasleyCharles Easley
Charles Easley

1 February 2022 in Atmospheric Environment
Verified
Journal Article
Closed access
KAKhairallah Atwi
Khairallah Atwi
Sarah WilsonSarah Wilson
Sarah Wilson
AMArnab Mondal
Arnab Mondal
RERobert Clayton Edenfield
Robert Clayton Edenfield
KCKrista Maye Crow
Krista Maye Crow
RSRawad Saleh
Rawad Saleh

10 June 2022 in Systems Biology in Reproductive Medicine
Verified
Journal Article
Open access
RSRose Schrott
Rose Schrott
KGKatherine W. Greeson
Katherine W. Greeson
DKDillon King
Dillon King
KCKrista Maye Crow
Krista Maye Crow
Charles EasleyCharles Easley
Charles Easley
SMSusan Murphy
Susan Murphy
Cannabis use in the United States is increasing, with highest consumption among men at their peak reproductive years. We previously demonstrated widespread changes in sperm DNA methylation with cannabis exposure in humans and rats, including genes important in neurodevelopment. Here, we use an in vitro human spermatogenesis model to recapitulate chronic cannabis use and assess DNA methylation at imprinted and autism spectrum disorder (ASD) candidate genes in spermatogonial stem cell (SSC)- and spermatid-like cells. Methylation at maternally imprinted genes SGCE and GRB10 was significantly altered in SSC- and spermatid-like cells, respectively, while PEG3 was significantly differentially methylated in spermatid-like cells. Two of ten randomly selected ASD candidate genes, HCN1 and NR4A2, had significantly altered methylation with cannabis exposure in SSC-like cells. These results support our findings in human cohorts and provide a new tool with which to gain mechanistic insights into the association between paternal cannabis use and risk of ASD in offspring.

Verified
Journal Article
Open access
PDF file
KCKrista Maye Crow
Krista Maye Crow
ICIn Ki Cho
In Ki Cho
RERobert Clayton Edenfield
Robert Clayton Edenfield
KEKristen F. Easley
Kristen F. Easley
APAna Planinic
Ana Planinic
Charles EasleyCharles Easley
Charles Easley
Semen parameters, including sperm counts, have rapidly declined in men across the globe over the last five decades. Although this decline remains unexplained, lifestyle factors may affect male fertility. Recently, several studies highlighted a potential link between non-steroidal anti-inflammatory drug (NSAID) usage, such as naproxen and ibuprofen, and declining male fertility. However, the mechanisms by which these common analgesics affect male fertility, including their effects on the blood–testis barrier (BTB), remain poorly characterized. Utilizing an in vitro rhesus macaque non-human primate (NHP) BTB model, we demonstrate that serum levels of naproxen and ibuprofen alter the function of BTB. Following short-term naproxen and ibuprofen treatment of NHP primary Sertoli cells, we show that these NSAIDs increase the transepithelial electrical resistance, indicating an overall strengthening of the Sertoli cell junctions. Furthermore, naproxen and ibuprofen treatment alter the expression of genes involved in maintaining the BTB. Specifically, the genes that were significantly expressed in response to ibuprofen exposure were enriched for human phenotypic abnormalities linked to male factor infertility. Together, these results suggest that short-term naproxen and ibuprofen treatment disrupt the function of the BTB by altering the integrity of the Sertoli cell junctions, proposing a potential role of NSAIDs in male factor infertility.